Asia-Pacific Multiple Myeloma Treatment Market Value Will Reach $2.8 Billion by 2021, Find New Report
The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, and Australia will rise in value from $1.7 billion in 2014 to $2.8 billion by 2021, representing a Compound Annual Growth Rate (CAGR) of 7.4%, according to new report.
View full press release